← All FR Documents
Notice

National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting

📖 Research Context From Federal Register API

Key Dates
Citation: 90 FR 24148
October 8-9, 2025.
Public Participation

In Plain English

What is this Federal Register notice?

This is a notice published in the Federal Register by Health and Human Services Department, National Institutes of Health. Notices communicate information, guidance, or policy interpretations but may not create new binding obligations.

Is this rule final?

This document is classified as a notice. It may or may not create enforceable regulatory obligations depending on its specific content.

Who does this apply to?

Consult the full text of this document for specific applicability provisions. The affected parties depend on the regulatory scope defined within.

When does it take effect?

October 8-9, 2025.

Why it matters: This notice communicates agency policy or guidance regarding applicable regulations.

Document Details

Document Number2025-10335
FR Citation90 FR 24148
TypeNotice
PublishedJun 6, 2025
Effective Date-
RIN-
Docket ID-
Pages24148–24148 (1 pages)
Text FetchedYes

Agencies & CFR References

CFR References:
None

Linked CFR Parts

PartNameAgency
No linked CFR parts

Paired Documents

TypeProposedFinalMethodConf
No paired documents

External Links

📋 Extracted Requirements 0 found

No extractable regulatory requirements found in this document. This is common for documents that:

  • Incorporate requirements by reference (IBR) to external documents
  • Are procedural notices without substantive obligations
  • Contain only preamble/explanation without regulatory text

Full Document Text (365 words · ~2 min read)

Text Preserved
<NOTICE> DEPARTMENT OF HEALTH AND HUMAN SERVICES <SUBAGY>National Institutes of Health</SUBAGY> <SUBJECT>National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting</SUBJECT> Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Board of Scientific Counselors, NIDDK. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting can be accessed from the NIH Videocast at the following link: <E T="03">https://videocast.nih.gov/.</E> The meeting will be closed to the public as indicated below in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended for the review, discussion, and evaluation of individual grant applications conducted by the National Institute Of Diabetes And Digestive And Kidney Diseases, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. <EXTRACT> <E T="03">Name of Committee:</E> Board of Scientific Counselors, NIDDK. <E T="03">Date:</E> October 8-9, 2025. <E T="03">Open:</E> October 08, 2025, 10:00 a.m. to 5:00 p.m. <E T="03">Agenda:</E> Introductions and Overview. <E T="03">Address:</E> National Institutes of Health, Building 10, 10 Center Drive, Bethesda, MD 20892 (Virtual Meeting). <E T="03">Closed:</E> October 09, 2025, 10:00 a.m. to 5:00 p.m. <E T="03">Agenda:</E> To review and evaluate personal qualifications and performance, and competence of individual Investigators. <E T="03">Address:</E> National Institutes of Health, Building 10, 10 Center Drive, Bethesda, MD 20892 (Virtual Meeting). <E T="03">Contact Person:</E> Michael W. Krause, Ph.D., Scientific Director, NIDDK, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health, Building 5, Room B104, Bethesda, MD 20892-1818, (301) 402-4633, <E T="03">mwkrause@helix.nih.gov.</E> <FP>(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)</FP> </EXTRACT> <SIG> <DATED>Dated: June 2, 2025.</DATED> <NAME>Bruce A. George,</NAME> Program Analyst, Office of Federal Advisory Committee Policy. </SIG> <FRDOC>[FR Doc. 2025-10335 Filed 6-5-25; 8:45 am]</FRDOC> </NOTICE>
This text is preserved for citation and comparison. View the official version for the authoritative text.